Mainstay Medical’s Chronic Low Back Pain Device Approved Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The company plans to launch the product in the first half of 2021. Source: Devices & Diagnostics Letter You Might Also Like FDA Grants Priority Review for Liso-Cel in B-cell Lymphoma February 24, 2020 FDA Eases Requirements for Repackaging of Propofol April 23, 2020 FDA Approves Immunomedic’s Breast Cancer Treatment Trodelvy April 23, 2020
